These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 313125)

  • 21. Impaired concanavalin A-inducible suppressor T-cell activity in active alcoholic liver disease.
    Kawanishi H; Tavassolie H; MacDermott RP; Sheagren JN
    Gastroenterology; 1981 Mar; 80(3):510-7. PubMed ID: 6450078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologic aspects of alcoholic liver disease.
    Zetterman RK; Sorrell MF
    Gastroenterology; 1981 Sep; 81(3):616-24. PubMed ID: 6166511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunology of alcoholic liver disease.
    Leevy CB; Elbeshbeshy HA
    Clin Liver Dis; 2005 Feb; 9(1):55-66. PubMed ID: 15763229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon production by peripheral blood cells of patients with alcoholic liver disease (ALD).
    Daniluk J; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 1994; 42(3):231-8. PubMed ID: 7487359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
    Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
    Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coagulation factors V and VIII in relation to severity and outcome in acute alcoholic hepatitis.
    Pereira LM; Langley PG; Bird GL; Hayllar KM; Tredger JM; Williams R
    Alcohol Alcohol; 1992 Jan; 27(1):55-61. PubMed ID: 1580929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [E rosette inhibition in alcoholic liver disease].
    Corrado S; Nacif O; Vilella C; Svampa S; Kremer A; Araujo H; Heinrichs G; Ríos B
    Medicina (B Aires); 1993; 53(1):29-34. PubMed ID: 8246727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Occurrence of increased alpha-fetoprotein in non-neoplastic hepatopathies of alcoholic or non-alcoholic origin].
    Pol S; Nalpas B; Bezeaud A; Bréchot C; Berthelot P
    Gastroenterol Clin Biol; 1986 Feb; 10(2):112-6. PubMed ID: 2422087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of human lymphocyte-mediated mitogen-induced cytotoxicity of murine L-929 cells by heterologous anti-human lymphotoxin antisera in vitro.
    Hiserodt JC; Granger GA
    J Immunol; 1977 Aug; 119(2):374-80. PubMed ID: 301888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological studies in patients with chronic active hepatitis. Cytotoxic activity of lymphocytes to autochthonous liver cells grown in tissue culture.
    Paronetto F; Vernace S
    Clin Exp Immunol; 1975 Jan; 19(1):99-104. PubMed ID: 1204242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels of intercellular adhesion molecule-1 in patients with alcoholic liver disease.
    Shimada S; Yamauchi M; Toda G
    Alcohol Alcohol Suppl; 1993; 1B():47-51. PubMed ID: 7911670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME; Hiserodt JC
    J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Determination of cholylglycine in alcoholic hepatopathies. Clinical usefulness].
    Pagani A; Pranzo A; Galante T
    Minerva Dietol Gastroenterol; 1985; 31(1):25-31. PubMed ID: 4000510
    [No Abstract]   [Full Text] [Related]  

  • 34. Helper and suppressor T lymphocyte function in severe alcoholic liver disease.
    McKeever U; O'Mahony C; Whelan CA; Weir DG; Feighery C
    Clin Exp Immunol; 1985 Apr; 60(1):39-48. PubMed ID: 3159525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease.
    García-Valdecasas-Campelo E; González-Reimers E; Santolaria-Fernández F; De la Vega-Prieto MJ; Milena-Abril A; Sánchez-Pérez MJ; Martínez-Riera A; Gómez-Rodríguez Mde L
    Alcohol Alcohol; 2006; 41(3):261-6. PubMed ID: 16476762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease--a double-blind, placebo-controlled trial.
    Bode C; Schäfer C; Fukui H; Bode JC
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1367-73. PubMed ID: 9394106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
    Fujimoto M; Uemura M; Nakatani Y; Tsujita S; Hoppo K; Tamagawa T; Kitano H; Kikukawa M; Ann T; Ishii Y; Kojima H; Sakurai S; Tanaka R; Namisaki T; Noguchi R; Higashino T; Kikuchi E; Nishimura K; Takaya A; Fukui H
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):48S-54S. PubMed ID: 10803780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Blood group, alcoholism and liver damage (author's transl)].
    Neukirchen M; Haase W
    MMW Munch Med Wochenschr; 1981 Jan; 123(4):129-32. PubMed ID: 6783879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered T-lymphocyte responsiveness to polyclonal cell activators is responsible for liver cell necrosis in alcohol-fed rats.
    Cao Q; Batey R; Pang G; Clancy R
    Alcohol Clin Exp Res; 1998 May; 22(3):723-9. PubMed ID: 9622456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocytotoxicity in acute and chronic alcoholic liver disease: "in vitro" study on effector cells.
    Miglio F; Stefanini GF; Bernardi M; Facchini A; Mariani E; Gasbarrini G
    Gastroenterol Clin Biol; 1979; 3(6-7):531-5. PubMed ID: 535720
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.